MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Cash and Bank History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash and Bank | ₹1,198 Cr | ₹453 Cr | ₹406 Cr | ₹701 Cr | ₹420 Cr |
What is the latest Cash and Bank ratio of MANKIND PHARMA ?
Year | Cash and Bank |
---|---|
Mar2024 | ₹1,198 Cr |
Mar2023 | ₹453 Cr |
Mar2022 | ₹406 Cr |
Mar2021 | ₹701 Cr |
Mar2020 | ₹420 Cr |
How is Cash and Bank of MANKIND PHARMA Trending?
Years | Cash and Bank | % Change | |
---|---|---|---|
Mar2024 | ₹1,198 Cr | 164.34 | |
Mar2023 | ₹453 Cr | 11.64 | |
Mar2022 | ₹406 Cr | -42.07 | |
Mar2021 | ₹701 Cr | 66.89 | |
Mar2020 | ₹420 Cr | - |
Compare Cash and Bank of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹106,888.2 Cr | -11.2% | -2.3% | 33.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,382.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,224.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,943.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,588.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,704.0 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -11.2% |
-2.3% |
33.6% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses